Targeted fluorescent probes for high-ccontrast cancer detection
Cancer is a universal issue that affects uncountably many people around the world. Many will turn to surgery…
Targeted PET/CT tracer improves early prediction of treatment response in rheumatoid arthritis patients
A new targeted PET/CT tracer can detect treatment response in rheumatoid arthritis patients in as little as four…
Combination therapy may help overcome barrier in early-stage prostate cancer treatment
A multi-institutional study led by Mayo Clinic and published in Cell Reports Medicine reports that pairing a next-generation immunotherapy with standard hormone therapy…
Progress toward a blood test for early pancreatic cancer
February 24, 2026 At a Glance Researchers identified markers in blood that could be used to identify people…
Assessing long-term cognitive risks in ependymoma survivors
A study led by St. Jude Children’s Research Hospital assessed cognitive and communication abilities in children treated for…
Remote-controlled CAR T cells offer safer cancer therapy
Among the most promising tools of cancer therapy, engineered immune cells known as chimeric antigen-receptor (CAR) T cells…
Researchers develop new score to predict the risk of liver cancer
Researchers led by Xian-Yang Qin at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan have developed…
Man Takes Sleep Meds Before Bed—What He Wakes Up to Unlocks ‘New Fear’
A doctor shared the scary story of what happened when he took his sleep medicine before bed, and…
Transcription factor HOXD13 drives melanoma growth and immune evasion
A molecule that helps regulate gene activity has also been shown to drive skin cancer growth and tumors’…
MHC class II marks stronger immune response and longer survival in ovarian cancer
A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond…
Nervous system actively promotes pre-cancerous pancreatic lesions
Pancreatic cancer has a lot of nerve. Notoriously tricky to detect, the disease also often resists traditional therapy.…
Tumor-targeted chimeric drug increases efficacy and limits side effects
Wistar scientists have combined a promising cancer therapy with a molecule that targets tumors to treat cancer more…